U.S. Blood Supply Safe From Zika Virus, Officials Say
They detail steps being taken to protect people who need transfusions
HealthDay News | 4/11/2017, 9:56 a.m.
U.S. blood banks are confident they have the tools to protect America's blood supply from possible new Zika virus outbreaks during the upcoming mosquito season.
A transfusion of Zika-tainted blood can pass the virus to an unsuspecting recipient, according to the U.S. Centers for Disease Control and Prevention.
But sophisticated genetic tests and blood processing procedures make it highly unlikely that anyone will contract Zika from donated blood, according to a series of articles in a special issue of the journal Transfusion.
Every blood donation in the United States undergoes testing for the presence of Zika virus, based on guidance from the U.S. Food and Drug Administration, said Susan Stramer, vice president of scientific affairs for the American Red Cross.
About 40 U.S. donations have tested positive for Zika since screening began, mostly in Florida, Stramer said.
Thanks to this testing, there have been no documented or alleged cases of Zika infection through blood transfusion in either the United States or its territories, said Dr. Louis Katz, chief medical officer of America's Blood Centers.
The risk "was low before donor screening and is an extremely remote possibility now, with donor blood screening in place," Katz said. "Further, women in the most vulnerable period of pregnancy for bad fetal outcomes are rarely transfused in the United States, so [Zika-related birth defects] are even remoter risks."
Zika causes no symptoms in 4 out of 5 people infected, so it's unlikely that most donors would suspect they're carrying the virus.
Zika poses its main threat to the unborn, increasing a pregnant woman's risk of delivering a baby with microcephaly or other birth defects. One out of 10 pregnant U.S. women with confirmed infection in 2016 had a fetus or baby affected by Zika-related birth defects, the CDC said.
Microcephaly causes newborns to have underdeveloped heads and brains.
Four people in Brazil have contracted Zika through blood from three infected donors, Stramer said. At that time, blood donations were not being effectively screened in that country.
U.S. blood banks use two tests that look for the genetic material of Zika in samples, Katz said. Any donations with potential infection are discarded.
Blood sample screening in the southern United States last year detected 23 potentially Zika-tainted donations out of nearly 360,000. Fourteen of those samples, all from Florida, were judged as probably infected based on further genetic testing and interviews with donors, according to one of the new studies.
Ten of the 14 donors reported travel to an active Zika transmission area within 90 days before donating blood, researchers reported. Two involved travel within the Miami outbreak area, while the rest involved travel to Puerto Rico, Jamaica, Trinidad, Mexico, Cuba or the Dominican Republic.
A second study reported detection of five Zika-tainted samples out of more than 466,000 donations across the entire United States, all linked to travel in Central or South America. The cases occurred in Arizona, California, Nevada, New York and Texas.
"We know these tests are extremely sensitive. They are much more sensitive than tests used in diagnostic public health labs," Stramer said. "It's highly unlikely that we would miss an infectious unit, but we never say never."